We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Allison Transmission
ALSN
$9.82B
| $30.7M | 0.07% |
635,273
-472,257
| -43% | -$21.9M |
|
|
SIVB
277
DELISTED
SVB Financial Group
SIVB
| $30.6M | 0.07% |
122,076
+37,378
| +44% | +$8.5M |
|
|
CVSA
278
Covista Inc
CVSA
$4.8B
| $30.6M | 0.07% |
876,219
+95,378
| +12% | +$3.28M |
|
279
Exelixis
EXEL
$13.4B
| $30.6M | 0.07% |
1,738,541
+1,654,141
| +1,960% | +$28M |
|
|
TERP
280
DELISTED
TerraForm Power, Inc
TERP
| $30.4M | 0.07% |
1,978,448
-642,883
| -25% | -$10.4M |
|
281
Cheniere Energy
LNG
$52.9B
| $30.4M | 0.07% |
497,537
+356,237
| +252% | +$21.9M |
|
282
Martin Marietta Materials
MLM
$33B
| $30.1M | 0.07% |
+107,800
| New | +$28.8M |
|
283
Sanmina
SANM
$10.9B
| $30.1M | 0.07% |
879,545
+505,541
| +135% | +$16.2M |
|
|
NUAN
284
DELISTED
Nuance Communications, Inc.
NUAN
| $30M | 0.07% |
+1,681,608
| New | +$27.9M |
|
285
Sensata Technologies
ST
$6.79B
| $29.9M | 0.07% |
555,460
+35,169
| +7% | +$1.81M |
|
286
Arrowhead Research
ARWR
$12.4B
| $29.9M | 0.07% |
+470,679
| New | +$23.4M |
|
287
Constellium
CSTM
$3.99B
| $29.8M | 0.07% |
2,227,356
+1,826,464
| +456% | +$25.2M |
|
288
GrafTech
EAF
$212M
| $29.7M | 0.07% |
255,421
+79,003
| +45% | +$9.93M |
|
289
Banco Santander
SAN
$210B
| $29.6M | 0.07% |
7,456,645
+802,637
| +12% | +$3.12M |
|
290
Incyte
INCY
$24.4B
| $29.4M | 0.07% |
336,572
+151,372
| +82% | +$12.9M |
|
|
LNW
291
DELISTED
Light & Wonder
LNW
| $29.4M | 0.07% |
1,096,936
+697,943
| +175% | +$18M |
|
292
CNX Resources
CNX
$5.2B
| $29.4M | 0.07% |
3,319,161
+1,033,357
| +45% | +$8.06M |
|
293
Nordson
NDSN
$17.3B
| $29.3M | 0.07% |
+179,944
| New | +$28.4M |
|
|
CPE
294
DELISTED
Callon Petroleum Company
CPE
| $29.3M | 0.07% |
605,836
+331,166
| +121% | +$13.7M |
|
|
NATI
295
DELISTED
National Instruments Corp
NATI
| $29.2M | 0.07% |
690,566
-285,506
| -29% | -$11.9M |
|
296
Regal Rexnord
RRX
$11.9B
| $29.2M | 0.07% |
340,912
+83,543
| +32% | +$6.62M |
|
297
United Parks & Resorts
PRKS
$2.12B
| $29.1M | 0.07% |
918,219
-769,493
| -46% | -$22.2M |
|
|
TMHC
298
DELISTED
Taylor Morrison
TMHC
| $28.8M | 0.07% |
1,317,892
+1,269,336
| +2,614% | +$30.5M |
|
299
Darden Restaurants
DRI
$24.4B
| $28.6M | 0.07% |
262,201
-1,401,194
| -84% | -$159M |
|
300
Medpace
MEDP
$16.5B
| $28.6M | 0.07% |
339,764
+273,504
| +413% | +$21.2M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.